Akoustis Technologies Inc buy HC Wainwright
Start price
31.03.26
/
50%
€0.001
Target price
31.03.27
€28.75
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 31.03.27. The prediction end date can be changed by HC_Wainwright at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akoustis Technologies Inc | - | - |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by HC_Wainwright for this prediction
In the thread Akoustis Technologies Inc diskutieren
Aktis Oncology (AKTS) had its price target raised by HC Wainwright from $30.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for AKTS provided by MarketBeat